arrow
S

Scott V. Bratman

university health network toronto
H指数:53
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Investigating the impact of margins on the management of oropharyngeal cancer treated with transoral robotic surgery: a survey of head and neck oncologists’ treatment patterns

探究切缘对经口机器人手术治疗口咽癌管理的影响:对头颈肿瘤医师治疗模式的调查

2026-09-190
PRE
Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status

转移模式、结局及按肿瘤HPV状态划分的原发转移性头颈癌的预后因素

2026-09-040
PRE
Validation of the ninth edition pathological and clinical TNM classifications for salivary gland carcinoma

第九版唾液腺癌病理与临床TNM分期的验证

2026-09-010
PRE
HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer

HPV血清学和循环病毒DNA在口咽癌中的检测、分型和疾病负担测量

2026-08-150
OAAI
Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma

使用列线图优化唾液腺癌辅助放疗决策

2026-04-170
PRE
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

1,294血浆无细胞DNA甲基化组和片段组的泛癌纲要,可进行多癌检测

2026-02-190
OAAI
Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab

一种组织无关的全基因组甲基组富集检测的临床验证,用于监测帕博利珠单抗的治疗反应

2026-02-130
OAAI
Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT

T2N0声门癌IMRT治疗后喉返神经麻痹的预后价值

2026-02-010
OAAI
Prevalence and Prognostic Value of Individual T4-defining Radiologic Features in HPV-Positive Oropharyngeal Carcinoma

HPV阳性口咽癌中单个T4定义影像学特征的发生率及预后价值

2025-12-230
PRE
Outcomes and characteristics of patients receiving pre-operative versus post-operative radiotherapy for sinonasal squamous cell carcinoma

接受术前与术后放疗的鼻腔及鼻窦鳞状细胞癌患者的结局与特征

2025-11-220
PRE
Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [64Cu]Cu-DOTA-Panitumumab F(ab′)2 and [177Lu]Lu-DOTA-Panitumumab F(ab′)2

正电子发射断层扫描/计算机断层扫描(PET/CT)和人源异种移植瘤模型中头颈癌患者来源的异种移植小鼠的放射免疫治疗,使用治疗诊断双功能试剂[64Cu]Cu-DOTA-Panitumumab F(ab′)2和[177Lu]Lu-DOTA-Panitumumab F(ab′)2。

2025-10-210
PRE
Dosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trial

SBRT治疗超中心型肺癌的剂量学结果:SUNSET试验的经验

2025-09-030
OAAI
Risk factors and survival impact of severe radiation-related late toxicities in head and neck cancer–a cohort study

头颈癌中严重放射相关性晚期毒性的危险因素及生存影响——一项队列研究

2025-09-030
PREAI